Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bausch + Lomb Corporation Common Shares
(NY:
BLCO
)
14.89
-0.09 (-0.60%)
Streaming Delayed Price
Updated: 11:21 AM EDT, Jun 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
105,340
Open
14.88
Bid (Size)
14.87 (200)
Ask (Size)
14.91 (100)
Prev. Close
14.98
Today's Range
14.80 - 15.02
52wk Range
11.22 - 18.91
Shares Outstanding
353,800,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
June 01, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 21, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Performance
YTD
-10.2%
-10.2%
1 Month
-8.7%
-8.7%
3 Month
-17.2%
-17.2%
6 Month
-12.7%
-12.7%
1 Year
+30.0%
+30.0%
More News
Read More
Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results
May 20, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest
May 19, 2026
Via
StockStory
Bausch + Lomb Corp (NYSE:BLCO) Beats Q1 Estimates, Raises Full-Year Guidance
↗
April 29, 2026
Via
Chartmill
Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States
May 19, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
3 Profitable Stocks We’re Skeptical Of
May 18, 2026
Via
StockStory
Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe
May 07, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Second R&D “Teach-in” Webinar
May 06, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb (BLCO) Q1 2026 Earnings Transcript
↗
April 30, 2026
Via
The Motley Fool
Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting
April 30, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026
April 29, 2026
Via
StockStory
Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook
April 29, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look For
April 27, 2026
Via
StockStory
Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration
April 23, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Releases 2025 Sustainability Impact Report
April 22, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch Lomb BLCO Q2 2025 Earnings Transcript
↗
April 21, 2026
Via
The Motley Fool
Bausch + Lomb (BLCO) Q3 2025 Earnings Transcript
↗
April 21, 2026
Via
The Motley Fool
Bausch + Lomb (BLCO) Q4 2025 Earnings Transcript
↗
April 21, 2026
Via
The Motley Fool
Topics
Initial Public Offering
Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program
April 16, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
3 Cash-Burning Stocks We Keep Off Our Radar
April 10, 2026
Via
StockStory
Topics
Bankruptcy
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update
April 08, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
April 08, 2026
Via
StockStory
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe
April 07, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting
April 06, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Frequently Asked Questions
Is Bausch + Lomb Corporation Common Shares publicly traded?
Yes, Bausch + Lomb Corporation Common Shares is publicly traded.
What exchange does Bausch + Lomb Corporation Common Shares trade on?
Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Bausch + Lomb Corporation Common Shares?
The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange
What is the current price of Bausch + Lomb Corporation Common Shares?
The current price of Bausch + Lomb Corporation Common Shares is 14.89
When was Bausch + Lomb Corporation Common Shares last traded?
The last trade of Bausch + Lomb Corporation Common Shares was at 06/03/26 11:21 AM ET
What is the market capitalization of Bausch + Lomb Corporation Common Shares?
The market capitalization of Bausch + Lomb Corporation Common Shares is 5.27B
How many shares of Bausch + Lomb Corporation Common Shares are outstanding?
Bausch + Lomb Corporation Common Shares has 5B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
